Pfizer Inc. is poised to highlight key advances from its oncology portfolio at the European Society for Medical Oncology (ESMO) Congress 2025, which runs from October 17 to 21 in Berlin. With over 45 abstracts, including 11 oral and mini oral...
Sandoz, a global leader in the supply of affordable medicines, announced the US market release of its generic iron sucrose injection, following the US Food and Drug Administration (FDA) approval made recently.
India and Mexico have opened up strategic talks that focus on expanding the Indian pharmaceutical industry's opportunities. The communication is designed to provide better access to cheaper drugs in Mexico
Alembic Pharmaceuticals Limited has announced today that it has obtained final approval from the US Food and Drug Administration (USFDA) for its Abbreviated New Drug Application (ANDA) pertaining to Paroxetine Extended-Release Tablets USP...
In order to emphasize the vital significance of fair access to contraceptive and reproductive health services across the Asia Pacific area, Organon, a worldwide healthcare organization dedicated to women's health, is working with regional partners
Illumina Inc. has announced global partnerships with top pharmaceutical companies for companion diagnostics (CDx) on Illumina’s TruSight Oncology (TSO) Comprehensive genomic profiling test. The collaboration focuses on KRAS alterations...
AbbVie, a global biopharmaceutical leader, hosted the National Conclave on World Retina Day at the India Habitat Centre, Delhi, which focused on Diabetic Macular Edema
Sanofi has declared a new $625 million multi-year capital commitment to its venture arm, Sanofi Ventures, bringing its total managed assets to over $1.4 billion. This is a considerable enlargement of the evergreen venture fund as it firmly...
Ipca Laboratories has made an accomplishment by signing a Technology Transfer and Joint Development Agreement that is definite with BioSimilar Sciences PR LLC (BSS).
Global Heart Hub and Novartis have put the spotlight on high Lipoprotein(a), or Lp(a), a genetic condition that is often overlooked that entails significant risk for cardiovascular disease such as heart attack and stroke...
, CDSCO.jpg "Fostering a Quality Culture in the Pharmaceutical Industry")